PeptiStar Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 24

PeptiStar General Information

Description

Developer of medium-sized molecule pharmaceutical components intended to support drug research, development, and commercial production. The company provides CMC development, process and analytical method development, GMP-compliant manufacturing, and production scale-up for complex compounds such as peptides, oligonucleotide-based substances, and conjugated drug compounds across discovery, clinical development, and commercial stages, enabling pharmaceutical companies to advance drug candidates and maintain stable and compliant manufacturing supply.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2-5-1 Mishima
  • Settsu, Osaka 566-0022
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Corporate Office
  • 2-5-1 Mishima
  • Settsu, Osaka 566-0022
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PeptiStar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 17-Apr-2025 Completed Generating Revenue
3. Early Stage VC 01-Dec-2020 Completed Generating Revenue
2. Seed Round 20-Apr-2018 $188M $188M Completed Generating Revenue
1. Joint Venture 01-Sep-2017 Completed Generating Revenue
To view PeptiStar’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PeptiStar Patents

PeptiStar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026095005-A1 Production of oligonucleic acid Pending 31-Oct-2024
JP-7367240-B1 Particle manufacturing device and frozen particle manufacturing method Active 19-May-2022
JP-2023171374-A Particle production device Pending 19-May-2022
JP-2023171213-A Particle production device and frozen particle production method Active 19-May-2022
EP-4365184-A1 Analysis method for peptide bound to carrier for liquid phase peptide synthesis Pending 02-Jul-2021 G01N30/26
To view PeptiStar’s complete patent history, request access »

PeptiStar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PeptiStar Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Development Bank of Japan Corporation Minority
Shimadzu (Japan) PE-Backed Company Minority
Sumitomo Chemical Corporation Minority
Toagosei Corporation Minority
Asahi Kasei Corporate Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

PeptiStar FAQs

  • When was PeptiStar founded?

    PeptiStar was founded in 2017.

  • Where is PeptiStar headquartered?

    PeptiStar is headquartered in Settsu, Japan.

  • What is the size of PeptiStar?

    PeptiStar has 100 total employees.

  • What industry is PeptiStar in?

    PeptiStar’s primary industry is Drug Discovery.

  • Is PeptiStar a private or public company?

    PeptiStar is a Private company.

  • What is PeptiStar’s current revenue?

    The current revenue for PeptiStar is .

  • How much funding has PeptiStar raised over time?

    PeptiStar has raised $205M.

  • Who are PeptiStar’s investors?

    Development Bank of Japan, Shimadzu (Japan), Sumitomo Chemical, Toagosei, and Asahi Kasei Corporate Venture Capital are 5 of 24 investors who have invested in PeptiStar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process